It is known that senescence-accelerated mouse-prone 8 (SAMP8) exhibits AD-like pathologies including abnormal expression of anti-aging factors as well as increased oxidative stress, neuroinflammation, Aβ deposits, tau hyperphosphorylation, ER stress, and cognitive dysfunction [50,51,52]. This evidence concerns the gene MAPT and Alzheimer disease.